TAK Other Income/Expenses (Net)
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) · Other Income/Expenses (Net)
TAK Other Income/Expenses (Net)
Latest reported-¥238.29B JPYperiod ending
TAK Other Income/Expenses (Net) · JPY (¥31.32B → -¥238.29B)
Annual Other Income/Expenses (Net)
High-resolution chart · PNG
TAK other income/expenses (net) history
Annual fiscal periods · JPY. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Other Income/Expenses (Net) (JPY) |
|---|---|
| -297,161,877,000 | |
| -167,502,000,000 | |
| -161,284,000,000 | |
| -115,415,000,000 | |
| -158,273,000,000 | |
| -143,034,000,000 | |
| -161,162,000,000 | |
| -110,073,000,000 | |
| -24,584,000,000 | |
| -12,521,000,000 | |
| -10,289,000,000 | |
| -16,183,000,000 | |
| 19,577,000,000 | |
| 10,563,000,000 | |
| -12,549,000,000 | |
| 4,488,000,000 | |
| -4,382,000,000 | |
| 92,078,000,000 | |
| 153,719,000,000 | |
| 166,879,000,000 | |
| 115,148,000,000 | |
| 55,824,000,000 | |
| 74,511,000,000 | |
| 121,212,000,000 | |
| 92,184,000,000 | |
| 36,974,000,000 | |
| 31,321,000,000 |